Cargando…

Safety and Efficacy Study of Collagenase Clostridium Histolyticum Applied With an Intensive Protocol in the Treatment of Peyronie's Disease

INTRODUCTION: Collagenase clostridium histolyticum (CCH) is a treatment for Peyronie's disease (PD) whose efficacy and safety has been demonstrated using a classic protocol and a shortened protocol. AIM: To evaluate the efficacy and safety of an even more intense protocol in which a CCH injecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Melgarejo-Segura, Mª Teresa, Funes-Padilla, Carlos, Morales-Martínez, Ana, López-Carmona-Pintado, Fernando, Arrabal-Martín, Miguel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240339/ https://www.ncbi.nlm.nih.gov/pubmed/34091243 http://dx.doi.org/10.1016/j.esxm.2021.100375

Ejemplares similares

Role of collagenase clostridium histolyticum in Peyronie’s disease
por: Peak, Taylor C, et al.
Publicado: (2015)

Collagenase Clostridium histolyticum in the treatment of Peyronie’s disease: patient selection and perspectives
por: Kuhlmann, Paige K, et al.
Publicado: (2017)

Collagenase clostridium histolyticum intralesional injections for the treatment of Peyronie’s disease: a safety profile
por: Yan, Sylvia, et al.
Publicado: (2017)

Efficacy and Safety of Collagenase Clostridium Histolyticum in the Treatment of Peyronie's Disease: An Evidence-Based Analysis
por: Cao, Dehong, et al.
Publicado: (2022)

AB041. Experience in the use of collagenase clostridium histolyticum in the management of Peyronie’s disease
por: Jad, Amr, et al.
Publicado: (2016)

Racial variations in response to intralesional collagenase clostridium histolyticum in men with Peyronie’s disease
por: Nguyen, Hoang Minh Tue, et al.
Publicado: (2017)

The Impact of Clostridium Histolyticum Collagenase on the Prevalence and Management of Peyronie's Disease in the United States
por: Sun, Andrew J., et al.
Publicado: (2019)

Peyronie’s disease – outcomes of collagenase clostridium histolyticum injection: A systematic review
por: Mefford, Austin T., et al.
Publicado: (2021)

Lateral herniation during treatment with collagenase Clostridium histolyticum (Xiaflex) for Peyronie’s disease
por: Gannon, Margaret K., et al.
Publicado: (2021)

Effect of collagenase Clostridium histolyticum on penile vascular and morphological parameters in patients with Peyronie’s disease
por: Diao, Linley, et al.
Publicado: (2017)

Complications and other concerns with intralesional injection therapy with collagenase clostridium histolyticum for Peyronie’s disease
por: Levine, Laurence A.
Publicado: (2017)

Expanding the role of injectable collagenase clostridium histolyticum for the treatment of active phase Peyronie’s disease
por: Aliperti, Louis A., et al.
Publicado: (2017)

Improvement in the ability to have sex in patients with Peyronie's disease treated with Collagenase Clostridium histolyticum
por: Geelhoed, Jeannette P., et al.
Publicado: (2022)

Collagenase Clostridium Histolyticum in the Treatment of Peyronie's Disease: Review of a Minimally Invasive Treatment Option
por: Gabrielson, Andrew T, et al.
Publicado: (2017)

The efficacy and safety of intralesional injection of collagenase Clostridium histolyticum for Peyronie’s disease: A meta-analysis of published prospective studies
por: Zhang, Fuxun, et al.
Publicado: (2022)

Changes in the Effects of Peyronie's Disease After Treatment With Collagenase Clostridium histolyticum: Male Patients and Their Female Partners
por: Goldstein, Irwin, et al.
Publicado: (2017)

Results of SMSNA survey regarding complications following intralesional injection therapy with collagenase clostridium histolyticum for Peyronie’s disease
por: Kadioglu, Ates, et al.
Publicado: (2017)

Surgical outcomes after collagenase Clostridium histolyticum failure in patients with Peyronie’s disease in a multicenter clinical study
por: Cocci, Andrea, et al.
Publicado: (2021)

Intralesional collagenase Clostridium histolyticum for acute phase Peyronie’s disease: a single-center, retrospective cohort study
por: Hu, Ming-Yeah Y., et al.
Publicado: (2022)

Safety and tolerability of collagenase Clostridium histolyticum and fasciectomy for Dupuytren’s contracture
por: Peimer, C. A., et al.
Publicado: (2015)

Re: Results of SMSNA survey regarding complications following intralesional injection therapy with collagenase clostridium histolyticum for Peyronie’s disease
por: Kahn, Barbara, et al.
Publicado: (2017)

Patient perspectives on Peyronie’s disease: results of poststudy interviews from a phase 2 trial of collagenase clostridium histolyticum
por: Kaminetsky, J., et al.
Publicado: (2018)

Editorial Comment: Impact of the advent of collagenase clostridium histolyticum on the surgical management of Peyronie's disease: a population-based analysis
por: Sukumar, S, et al.
Publicado: (2020)

How Atypical Penile Curvature Influence Clinical Outcomes in Patients with Peyronie's Disease Receiving Collagenase Clostridium Histolyticum Therapy?
por: Cocci, Andrea, et al.
Publicado: (2020)

Penile surgery for patients with Peyronie’s disease initially treated with collagenase clostridium histolyticum or surgery: a claims database analysis
por: Trost, Landon, et al.
Publicado: (2022)

Monitoring the Degradation of Collagen Hydrogels by Collagenase Clostridium histolyticum
por: Ng, Hon Wei, et al.
Publicado: (2020)

Treatment Patterns and Healthcare Outcomes with Collagenase Clostridium Histolyticum vs Surgery in Peyronie's Disease: A Retrospective Claims Database Analysis
por: Trost, Landon, et al.
Publicado: (2021)

Efficacy, Safety, and Durability of Response of Collagenase Clostridium Histolyticum-aaes for Treating Cellulite
por: Kaufman-Janette, Joely A., et al.
Publicado: (2020)

Treatment of Peyronie’s disease via preoperative intralesional collagenase clostridium histolyticum followed by placement of an inflatable penile prosthesis: the new standard of care?
por: Akerman, Jason, et al.
Publicado: (2017)

The emerging role of Clostridium histolyticum collagenase in the treatment of Dupuytren disease
por: Thomas, Alexis, et al.
Publicado: (2010)

Collagenase Clostridium histolyticum : emerging practice patterns and treatment advances
por: Warwick, David, et al.
Publicado: (2016)

New Considerations in the Use of Collagenase Clostridium Histolyticum for the Treatment of Cellulite
por: Grekin, Jeremy A, et al.
Publicado: (2023)

Collagenase clostridium hystolyticum in the management of Peyronie’s disease
por: Ahn, Sun Tae, et al.
Publicado: (2017)

Acute Pain Intensity After Collagenase Clostridium histolyticum Injection in Patients With Dupuytren Contracture
por: Noto, Kimitoshi, et al.
Publicado: (2019)

Safety of Xiaflex® (Collagenase Clostridium histolyticum) Treatment for Adult Anterior Urethral Stricture Disease
por: Wiegand, Lucas R, et al.
Publicado: (2023)

Late Complications of Clinical Clostridium Histolyticum Collagenase Use in Dupuytren's Disease
por: Rozen, Warren M., et al.
Publicado: (2012)

Intralesional collagenase clostridium histolyticum study provides real-world analysis
por: Haney, Nora M., et al.
Publicado: (2016)

Editorial Comment: Comparative Cost-effectiveness of Surgery, Collagenase Clostridium Histolyticum, and Penile Traction Therapy in Men with Peyronie's Disease in an Era of Effective Clinical Treatment
por: Wymer, K, et al.
Publicado: (2020)

Efficacy and safety of collagenase clostridium histolyticum for Dupuytren disease nodules: a randomized controlled trial
por: Costas, Bronier, et al.
Publicado: (2017)

Multiple concurrent collagenase clostridium histolyticum injections to dupuytren’s cords: an exploratory study
por: Coleman, Stephen, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_o5ma1fek4v8a0lg1uuq0ttmp1h